Abstract
Background During the COVID-19 pandemic, medical education migrated to digital environments, without clear guidelines for virtual courses or evaluations of how these courses have been developed.
Objective To adapt and validate a scale to evaluate the quality of virtual courses developed for human medicine students in Peru.
Methods Cross-sectional study that adapted a scale to assess the quality of virtual courses to the context of Peruvian medical students during the COVID-19 pandemic, using the Delphi methodology and pilot tests for a rigorous evaluation of the items, resulting in a scale of 30 items that were described with summary statistics. In addition to the exploratory factor analysis (EFA) with Oblimin rotation, together with the adequacy and sample fit with Bartlett test and Kaiser-Meyer-Olkin (KMO), while the internal consistency was estimated with the alpha coefficient.
Results A total of 297 medical students in Peru were surveyed. The descriptive statistics for the items showed a normal distribution, while the Bartlett test showed no inadequacy (X2=6134.34, p<0.01) and with the KMO test an overall value greater than 0.92 was found, therefore an AFE was performed where five factors were identified (General Quality and Didactic Methodology, Design and Navigation of the Virtual Platform, Multimedia Resources, Academic Materials) with 30 items. In the internal consistency, an alpha coefficient greater than 0.85 was estimated for the factors evaluated.
Conclusions The adapted scale of 30 items grouped into five factors or domains, show adequate evidence of validity and reliability to be used in the evaluation of the quality of virtual courses developed for Peruvian human medicine students during the context of the COVID-19 pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was submitted and reviewed by the research ethics committee of the Hospital Nacional Almanzor Aguinaga Asenjo of Peru, obtaining the ethical approval for the study with the resolution NTI-75502021030, this was obtained before of starting the pilot study and data collection.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of interest: None
Funding: None
Declaration of Interest: None
Data Availability
The data produced for this work are contained in the manuscript
